Article Text

Download PDFPDF
O13 Managing Mpox: a novel technological solution for a neglected infection
  1. Michael Rayment1,
  2. Stephen Cole1,
  3. Joseph Heskin1,
  4. Christopher Scott1,
  5. Ruth Byrne1,
  6. Nicolo Girometti1,
  7. Lauren Bull1,
  8. John McSorley2,
  9. Gabriel Wallis2,
  10. Olamide Dosekun3,
  11. Rachael Jones1
  1. 1Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
  2. 2London North West University Healthcare NHS Trust, London, UK
  3. 3Imperial College Healthcare NHS Trust, London, UK

Abstract

Introduction The Mpox epidemic placed unprecedented strain on sexual health services: 9% of patients locally required hospitalisation, and the remainder required a daily welfare check by telephone. Remote monitoring systems (RMS) offer effective management of patients within their own homes, affording an opportunity for the management of Mpox.

Methods An existing RMS, in operation in our hospital network, was repurposed to facilitate Mpox management. Mpox training was provided for the RMS nursing team. A bespoke module was developed within Luscii (a GDPR-compliant smartphone app) to support the service. We wished to evaluate the clinical utility of the app in supporting the RMS.

Results 729 patients were referred to the RMS. 221 individuals (30.3%) onboarded with the app, of whom eight later de-registered. The remainder (508/729; 69.7%) elected for daily telephone contact.

Overall, 3646 virtual reviews were performed by telephone and/or the app. At least one trigger was generated by 180/213 app-registered individuals (84.5%). 51/180 (28.3%) required escalation to the on-call sexual health clinician. The remainder were managed by RMS staff by telephone.

Of the 51 individuals requiring intervention, 41/51 (80.4%) attended sexual health services for face-to-face review.

Most escalation alerts (46/51; 90.2%) related to complications of Mpox lesions, of which 38/46 (82.6%) were ano-genital. Other escalations resulted from reports via the app of back pain (1/51; 1.9%), headache (1/51; 1.9%), and low mood (2/51; 3.9%).

Overall, three of the onboarded cohort (3/213 (1.4%) were admitted for inpatient care.

Conclusion The RMS, underpinned by the Luscii app, proved an effective intervention for managing Mpox in an outpatient setting.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.